Mar-Frin en es it fr

Mar-Frin Brand names, Mar-Frin Analogs

Mar-Frin Brand Names Mixture

  • No information avaliable

Mar-Frin Chemical_Formula


Mar-Frin RX_link

Mar-Frin fda sheet

Mar-Frin FDA

Mar-Frin msds (material safety sheet)

Mar-Frin MSDS

Mar-Frin Synthesis Reference

Stahmann, et al., U.S. Pat. 2,427,578 (1947)

Mar-Frin Molecular Weight

308.328 g/mol

Mar-Frin Melting Point

161 oC

Mar-Frin H2O Solubility

17 mg/L

Mar-Frin State


Mar-Frin LogP


Mar-Frin Dosage Forms

Powder for solution; Tablet

Mar-Frin Indication

For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.

Mar-Frin Pharmacology

Warfarin, a coumarin anticoagulant, is a racemic mixture of two active isomers. It is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).

Mar-Frin Absorption

No information avaliable

Mar-Frin side effects and Toxicity

LD50=374 (orally in mice)

Mar-Frin Patient Information

No information avaliable

Mar-Frin Organisms Affected

Humans and other mammals